1Wei LH, Kuo ML, Chen CA, et al.Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.Oncogene,2003,22:1517-1527.
2Wei LH, Kuo ML, Chen CA, et al. Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor. Gynecol Oncol, 2001, 82:49-56.
3Scambia G, Testa U, Panici PB, et al. Interleukin-6 serum levels in patients with gynecological tumors. Int J Cancer, 1994,57:318-323.
4Tartour E, Gey A, Sastre-Garau X, et al. Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma.Cancer Res, 1994, 54:6243-6248.
5Srivani R, Nagarajan B. A prognostic insight on in vivo expression of interleukin-6 in uterine cervical cancer. Int J Gynecol Cancer,2003,13:331-339.
6Klein B, Zhang XG, Lu ZY, et al. Interleukin-6 in human multiple myeloma.Blood, 1995,85:863-872.
7Okamoto M, Lee C, Oyasu R. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro.Cancer Res, 1997,57:141-146.
8Eustace D, Han X, Gooding R, et al.Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro. Gynecol Oncol,1993,50:15-19.
